An observational study in Pregnancy Loss and Infant Death, sponsored by Centre Hospitalier Universitaire de la Réunion. Terminated at 1 site in Réunion. Open to female participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2019-03-07.
Sponsored by Centre Hospitalier Universitaire de la Réunion · Observational
Infant mortality is still relevant despite the improvement and the accessibility of hospital care. Premature birth are two fold higher than in metropolitan France. Some factors has been suspected such as precariousness, alcoholism, congenital malformation, care accessibility, epidemic environment ... Nevertheless, the impact of these factors on foetal death or new-born death are not yet sufficiently quantified to provide appropriate care and prevention action in Reunion Island.
Through the analysis of interview of the mothers that have lost their infant during pregnancy or just after birth, the study aims to draw a picture of the pregnancy cares offer and pregnancy conditions in Reunion Island.
This study is an non interventional case-control study. Socio-economic conditions, pregnancy care and prevention are screened to identified the major cause of foetal or new-born death in Reunion Island. These data are still lacking and will be useful to identify which public health actions that should be organized.
51 studies on the registry are indexed under Infant Death; 15 are open to participants now.
This study's enrollment of 45 is below the median of 368 across 11 observational studies indexed under Infant Death.
Browse Infant Death studies →Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 141 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pregant women or mother leaving in Reunion Island. Case and control women should have stay during all their pregancy and should have been admitted in an hospital in Reunion Island for delivery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In-utero dead foetus weighting at least 500 g or 22-amenorrhea weeks old. In utero death means that death occurs during delivery or per partum
Other: Foetal death
New-born dead during post-birth hospital stay and at least 23-amenorrhea weeks old.
Other: New-born death
Same gender child born, and alive, in the same hospital, and born on time (37-41 amenorrhea weeks old).
Other: Birth control for foetal death
Same gender infant born, and alive, in the same hospital, and: * for 23-amenorrhea weeks old new-born death: control new-born are born on time (37-41 amenorrhea weeks old). * for 24 to 31-amenorrhea weeks old new-born death: control new-born are premature infant (24-31 amenorrhea weeks old), and are included when their hospital stay ends. * for 32 and more-amenorrhea weeks old new-born death: control new-born are 32 and more-amenorrhea weeks old infant
Other: Birth control for new-born death
A midwife is in charge to interview the mother during the month following the lost of her infant.
A midwife is in charge to interview the mother during the month following the lost of her infant.
A midwife is in charge to interview the mother during her hospital stay
A midwife is in charge to interview the mother during her hospital stay
Rate of suboptimal care
The main suboptimal care are searched: * lack or inefficient corticotherapy during pregnancy * infant birth in an under equipped hospital, without facilities for premature birth * prenatal diagnosis of serious congenital malformations involving specific care at birth * lack of B-streptococcus detection * unexpected caesarean section during delivery * unexpected dystocia
Time frame: within 4 weeks after birth (control) or lost (case)
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2017 to primary completion in Sep 2018, 17 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de la Réunion →